Skip to Content


In the US, Loxapine (loxapine systemic) is a member of the drug class miscellaneous antipsychotic agents and is used to treat Agitated State, Agitation and Schizophrenia.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Neuroleptic agent

Dopamine antagonist

Chemical Names

2-Chloro-11-(4-metyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine (WHO)

Dibenz[b,f][1,4]oxazepine, 2-chloro-11-(4-metyl-1-piperazinyl)- (USAN)

Foreign Names

Generic Names

  • Loxapina (OS: DCIT)
  • Loxapine (OS: BAN, DCF, USAN)
  • AZ-004 (IS)
  • BRN 0626753 (IS)
  • CL 62362 (IS: Lederle)
  • HF 3170 (IS)
  • LW 3170 (IS)
  • Oxilapine (IS)
  • S 805 (IS)
  • Staccato loxapine (IS)
  • SUM 3170 (IS)
  • UNII-LER583670J (IS)
  • UNII-376MYL4MAL (IS)
  • Loxapine Succinate (OS: USAN)
  • CL 71563 (IS: Lederle)
  • Loxapin hydrogensuccinat (IS)
  • Loxapine Succinate (PH: USP 38)

Brand Names

  • Adasuve
    Alexa, Slovenia; Alexza, Austria; Alexza, Norway; Alexza, Romania; Alexza UK, Poland; Bioprojet, France; Ferring, Slovakia; Medivir, Denmark; Medivir, Finland; Medivir, Sweden; Teva, United States; Trommsdorff, Germany
  • Loxapac
    Eisai, France; Wyeth, India
  • Loxapine Delta
    Delta Pharma, Egypt
  • Rosup
    Swiss Pharm, Taiwan
  • Loxapac
    Sandoz, Canada
  • Apo-Loxapine
    Apotex, Canada
  • Lopac
    Newai Chem, Taiwan
  • Losagen
    Patron, Taiwan
  • Loxapac
    Eisai, France; Pfizer, Taiwan
  • Loxapine
    Hisun Pfizer, China
  • Loxapine Succinate Actavis
    Actavis, United States
  • Loxitane
    Actavis, United States
  • Xylac
    PendoPharm, Canada


BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.